Download A4Medicine Mobile App
Empower Your RCGP AKT Journey: Master the MCQs with Us! π
Try Now
!
LOGIN
OR
REGISTER
0
HOME
MEDICAL TOPICS
REVISION
BOOKS
WEBINARS
Future Webinars
Past Webinars
PANELISTS
PLANS
CHAT ZONE
LOGIN
REGISTER
Go
0
1.
Gravesβ Disease : Introduction
2.
Hyperparathyroidism : Comparative Overview of types( Primary, Secondary, and Tertiary )
3.
Sodium-glucose co-transporter-2 (SGLT2) inhibitors in adults with type 2 diabetes
4.
Acromegaly
5.
Acromegaly- quick review card
6.
ACTH-Secreting Tumours : RCGP Curriculum Context
7.
ADA-EASD-guideline on management of Type 2 Diabetes
8.
Addison's disease
9.
Addisonβs disease
10.
Adrenal gland- Quick revision card
11.
Adrenal insufficiency : When to suspect ( NICE guidance summary )
12.
Adrenal insufficiency ( Hypoadrenalism )
13.
Amiodarone and thyroid function
14.
Androgen Insensitivity Syndrome (AIS)
15.
Association of Diabetes with Other Immunological Conditions
16.
Bone Profile and calcium metabolism : a clinician's guide
17.
Calcium Low ( Hypocalcemia ) : Acute Management
18.
Carbimazole
19.
CKD and Calcium Metabolism: Key Points for GP's
20.
Congenital adrenal hyperplasia β Quick review chart
21.
Cushingβs syndrome β Quick revision card
22.
Delayed puberty -Quick review chart
23.
Diabetes β complications quick review chart
24.
Diabetes : diagnosis
25.
Diabetes : Gestational ( NICE recommendations summary )
26.
Diabetes : types ( Overview )
27.
Diabetes foot check
28.
Diabetes Ketoacidosis ( DKA )
29.
Diabetes Type 2 : Diagnosis
30.
Diabetes- Macrovascular complications
31.
Diabetes-Alphabet Strategy
32.
Diabetes-prescribing in renal impairment
33.
Diabetes-Referral guide
34.
Diabetic Eye Screening Programme β NHS
35.
Diabetic foot infection β quick review chart
36.
Diabetic foot problem β risk assessment
37.
Diabetic foot ulcer β Quick review chart
38.
Diabetic Ketoacidosis (DKA) ; Ketones
39.
Emergency management of hyperglycemia- RACGP_ADS
40.
Endocrine Manifestations of Non-Endocrine Diseases
41.
Flushing patient
42.
Glucagon-like peptide ( GLP-1 ) receptor agonists ( GLP-1 RAs )
43.
Goiter
44.
Haemochromatosis & Disorders of Iron Metabolism: GP Guide
45.
Hashimoto thyroiditis
46.
Hirsutism
47.
Hyperaldosteronism β Quick revision chart
48.
Hypercalcaemia β raised calcium
49.
Hypercalcemia ( Raised calcium ) : Acute management
50.
Hyperhidrosis β Quick review chart
51.
Hyperkalaemia- Raised Potassium
52.
Hyperlipidaemias in Primary Care: Familial and Acquired Causes, Diagnosis, and Management
53.
Hypernatraemia- Raised sodium
54.
Hyperosmolar hyperglycemic syndrome ( HHS )
55.
Hyperparathyroidism β Quick revision card
56.
Hyperprolactinemia
57.
Hyperthyroidism
58.
Hyperuricemia
59.
Hypocalcemia-Low calcium
60.
Hypoglycemia β quick revision card
61.
Hypoglycemic agents : overview
62.
Hypokalaemia in adults- treatment
63.
Hypokalaemia- Low potassium
64.
Hypomagnesemia
65.
Hyponatremia ( Low Sodium )
66.
Hyponatremia ( Low Sodium ) ACUTE : Management in primary care
67.
Hypoparathyroidism -Quick revision chart
68.
Hypopituitarism -Quick review card
69.
Hypothalamic Causes of Hormonal Disturbances Understanding Central Dysregulation of Endocrine Function
70.
Hypothyroidism
71.
Impaired Fasting Glucose (IFG) : Introduction
72.
Impaired Glucose Tolerance (IGT) β Guide for primary care clinicians
73.
Injectable Medications for Diabetes Management GLP-1 Agonists & Insulin: Regimens, Administration, and Dosages
74.
Insulin chart
75.
Insulin Resistance β GP Guide
76.
Insulin Types, Brand Names, Manufacturers, and Delivery Devices
77.
Introduction: Pre-diabetes in Primary Care
78.
Investigating Suspected Thyroid Dysfunction
79.
Ketone testing interpretation
80.
Latent autoimmune diabetes in adults (LADA) : a guide for GPs
81.
Liraglutide Use for Managing Overweight and Obesity: Eligibility and Rationale
82.
Low phosphate
83.
Male hypogonadism
84.
Metformin -Quick revision card
85.
Multiple Endocrine Neoplasia -Quick review card
86.
Neck lumps : differentials
87.
Oral Glucose Tolerance Test (OGTT)
88.
Osteomalacia and Rickets β Quick revision card
89.
Osteoporosis
90.
Osteoporosis : Bisphosphonates
91.
Osteoporosis : Fragility fracture risk score interpretation
92.
Pagets disease of bone β quick review card
93.
Pheochromocytoma
94.
Pheochromocytoma : A review
95.
Pituitary adenoma β Quick review card
96.
Pituitary apoplexy β Quick review chart
97.
Polyuria and polydipsia
98.
Potassium
99.
Precocious puberty β Quick review card
100.
Primary Hyperparathyroidism
101.
Primary hyperparathyroidism β Quick review chart
102.
Primary hypothyroidism -management and follow up
103.
Rickets versus osteomalacia
104.
Sick euthyroid sydrome (The Non-Thyroidal Illness Syndrome)
105.
Sodium Glucose Cotransporter -2 (SGLT2 ) Inhibitors -Gliflozins
106.
Sodium-Glucose Cotransporter Inhibitors ( SGLT2 )
107.
Subclinical hyperthyroidism
108.
Subclinical hypothyroidism : diagnosis and management in adults, summary ( NICE )
109.
Testosterone : Raised ( total ) causes
110.
Testosterone deficiency syndrome
111.
Thyroid Cancer
112.
Thyroid Function Tests : Interpretation
113.
Thyroid hormones : Overview
114.
Thyroidits
115.
Type 1 diabetes β suspecting in children 0-19 pathway
116.
Type 2 diabetes
117.
Type 2 diabetes β Gastroparesis
118.
Type 2 diabetes β Insulin therapy
119.
Type 2 diabetes β self monitoring of blood glucose ( SMBG )
120.
Type 2 diabetes : detailed stepwise treatment recommendations ( NICE )
121.
Type 2 diabetes & CKD : SGLT2 inhibitors
122.
Type 2 Diabetes in Adults : Management NICE guidance June 2022
123.
Type 2 Diabetes Management : Main Classes of Medications
124.
Type 2 Diabetes NICE targets
125.
Vitamin D deficiency
126.
Vitamin D Deficiency : Management
127.
WHO Diagnostic criteria diabetes